Antacids Market Growth Prospect, End-User Analysis and Future Projections till 2025
The scope of the global Antacids Market was appreciated at US$ 5.83 billion in 2017. The range is projected to touch US$ 7.91 billion by 2025, growing at a CAGR of 3.9% for the duration of the forecast. This could be due to increase in geriatric population encountering GERD (Gastroesophageal reflux disease), poor eating habits causing acidity, and the ill-effects of anti-inflammatory, non-steroidal drugs.
The scope of the global Antacids Market was appreciated at US$ 5.83 billion in 2017. The range is projected to touch US$ 7.91 billion by 2025, growing at a CAGR of 3.9% for the duration of the forecast. This could be due to increase in geriatric population encountering GERD (Gastroesophageal reflux disease), poor eating habits causing acidity, and the ill-effects of anti-inflammatory, non-steroidal drugs.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
The players contributing to the antacids market include Bayer AG, AstraZeneca PLC, Sanofi S.A., Reckitt Benckiser
Group PLC, Procter & Gamble, Pfizer Inc., Johnson & Johnson, and Dr. Reddy’s Laboratories Ltd.
Request Sample Copy of This Report @
https://www.millioninsights.com/industry-reports/antacids-market/request-sample
Market Segment:
Antacid Dosage Form Outlook (Revenue, USD Million, 2014 - 2025)
• Tablet
• Liquid
• Others
Antacid Distribution Channel Outlook (Revenue, USD Million, 2014 - 2025)
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
Antacid Regional Outlook (Revenue, USD Million, 2014 - 2025)
• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• Asia Pacific
• Japan
• China
Change language